150 related articles for article (PubMed ID: 38183173)
1. Achaete-scute family bHLH transcription factor 2 activation promotes hepatoblastoma progression.
Kato Y; Fukazawa T; Tanimoto K; Kanawa M; Kojima M; Saeki I; Kurihara S; Touge R; Hirohashi N; Okada S; Hiyama E
Cancer Sci; 2024 Mar; 115(3):847-858. PubMed ID: 38183173
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-200 (miR-200) cluster regulation by achaete scute-like 2 (Ascl2): impact on the epithelial-mesenchymal transition in colon cancer cells.
Tian Y; Pan Q; Shang Y; Zhu R; Ye J; Liu Y; Zhong X; Li S; He Y; Chen L; Zhao J; Chen W; Peng Z; Wang R
J Biol Chem; 2014 Dec; 289(52):36101-15. PubMed ID: 25371200
[TBL] [Abstract][Full Text] [Related]
3. Bufalin inhibits gastric cancer invasion and metastasis by down-regulating Wnt/ASCL2 expression.
Wang J; Cai H; Xia Y; Wang S; Xing L; Chen C; Zhang Y; Xu J; Yin P; Jiang Y; Zhao R; Zuo Q; Chen T
Oncotarget; 2018 May; 9(34):23320-23333. PubMed ID: 29805736
[TBL] [Abstract][Full Text] [Related]
4. Ascl2 knockdown results in tumor growth arrest by miRNA-302b-related inhibition of colon cancer progenitor cells.
Zhu R; Yang Y; Tian Y; Bai J; Zhang X; Li X; Peng Z; He Y; Chen L; Pan Q; Fang D; Chen W; Qian C; Bian X; Wang R
PLoS One; 2012; 7(2):e32170. PubMed ID: 22384170
[TBL] [Abstract][Full Text] [Related]
5. HIF-1α/Ascl2/miR-200b regulatory feedback circuit modulated the epithelial-mesenchymal transition (EMT) in colorectal cancer cells.
Shang Y; Chen H; Ye J; Wei X; Liu S; Wang R
Exp Cell Res; 2017 Nov; 360(2):243-256. PubMed ID: 28899657
[TBL] [Abstract][Full Text] [Related]
6. WiNTRLINC1/ASCL2/c-Myc Axis Characteristics of Colon Cancer with Differentiated Histology at Young Onset and Essential for Cell Viability.
Yokota K; Tanaka Y; Harada H; Kaida T; Nakamoto S; Soeno T; Fujiyama Y; Yokota M; Kojo K; Miura H; Yamanashi T; Sato T; Nakamura T; Watanabe M; Yamashita K
Ann Surg Oncol; 2019 Dec; 26(13):4826-4834. PubMed ID: 31549316
[TBL] [Abstract][Full Text] [Related]
7. R-spondin1/Wnt-enhanced Ascl2 autoregulation controls the self-renewal of colorectal cancer progenitor cells.
Ye J; Liu S; Shang Y; Chen H; Wang R
Cell Cycle; 2018; 17(8):1014-1025. PubMed ID: 29886802
[TBL] [Abstract][Full Text] [Related]
8. Systematic analysis of the achaete-scute complex-like gene signature in clinical cancer patients.
Wang CY; Shahi P; Huang JT; Phan NN; Sun Z; Lin YC; Lai MD; Werb Z
Mol Clin Oncol; 2017 Jan; 6(1):7-18. PubMed ID: 28123722
[TBL] [Abstract][Full Text] [Related]
9. Achaete scute-like 2 suppresses CDX2 expression and inhibits intestinal neoplastic epithelial cell differentiation.
Shang Y; Pan Q; Chen L; Ye J; Zhong X; Li X; Meng L; Guo J; Tian Y; He Y; Chen W; Peng Z; Wang R
Oncotarget; 2015 Oct; 6(31):30993-1006. PubMed ID: 26307678
[TBL] [Abstract][Full Text] [Related]
10. Achaete-scute like 2 (ascl2) is a target of Wnt signalling and is upregulated in intestinal neoplasia.
Jubb AM; Chalasani S; Frantz GD; Smits R; Grabsch HI; Kavi V; Maughan NJ; Hillan KJ; Quirke P; Koeppen H
Oncogene; 2006 Jun; 25(24):3445-57. PubMed ID: 16568095
[TBL] [Abstract][Full Text] [Related]
11. Ionizing Radiation Promotes Epithelial-Mesenchymal Transition Phenotype and Stem Cell Marker in The Lung adenocarcinoma: In Vitro and Bioinformatic Studiesc.
Raei M; Bagheri M; Aghaabdollahian S; Ghorbani M; Sadeghi A
Cell J; 2022 Sep; 24(9):522-530. PubMed ID: 36274205
[TBL] [Abstract][Full Text] [Related]
12. Elevated ASCL2 expression in breast cancer is associated with the poor prognosis of patients.
Xu H; Zhao XL; Liu X; Hu XG; Fu WJ; Li Q; Wang Y; Ping YF; Zhang X; Bian XW; Yao XH
Am J Cancer Res; 2017; 7(4):955-961. PubMed ID: 28469967
[TBL] [Abstract][Full Text] [Related]
13. Ascl2 activation by YAP1/KLF5 ensures the self-renewability of colon cancer progenitor cells.
Wei X; Ye J; Shang Y; Chen H; Liu S; Liu L; Wang R
Oncotarget; 2017 Dec; 8(65):109301-109318. PubMed ID: 29312609
[TBL] [Abstract][Full Text] [Related]
14. Achaete-scute complex homologue-1 promotes development of laryngocarcinoma via facilitating the epithelial-mesenchymal transformation.
Ma H; Du X; Zhang S; Wang Q; Yin Y; Qiu X; Da P; Yue H; Wu H; Xu F
Tumour Biol; 2017 Jun; 39(6):1010428317705752. PubMed ID: 28618959
[TBL] [Abstract][Full Text] [Related]
15. DPEP1 promotes drug resistance in colon cancer cells by forming a positive feedback loop with ASCL2.
Zeng C; Qi G; Shen Y; Li W; Zhu Q; Yang C; Deng J; Lu W; Liu Q; Jin J
Cancer Med; 2023 Jan; 12(1):412-424. PubMed ID: 35670012
[TBL] [Abstract][Full Text] [Related]
16. Aberrant upregulation of ASCL2 by promoter demethylation promotes the growth and resistance to 5-fluorouracil of gastric cancer cells.
Kwon OH; Park JL; Baek SJ; Noh SM; Song KS; Kim SY; Kim YS
Cancer Sci; 2013 Mar; 104(3):391-7. PubMed ID: 23181270
[TBL] [Abstract][Full Text] [Related]
17. ASCL2 Affects the Efficacy of Immunotherapy in Colon Adenocarcinoma Based on Single-Cell RNA Sequencing Analysis.
Wu L; Sun S; Qu F; Liu X; Sun M; Pan Y; Zheng Y; Su G
Front Immunol; 2022; 13():829640. PubMed ID: 35774798
[TBL] [Abstract][Full Text] [Related]
18. ASCL2 expression contributes to gastric tumor migration and invasion by downregulating miR223 and inducing EMT.
Zuo Q; Wang J; Chen C; Zhang Y; Feng DX; Zhao R; Chen T
Mol Med Rep; 2018 Oct; 18(4):3751-3759. PubMed ID: 30106147
[TBL] [Abstract][Full Text] [Related]
19. Transcription factor achaete-scute homologue 2 initiates follicular T-helper-cell development.
Liu X; Chen X; Zhong B; Wang A; Wang X; Chu F; Nurieva RI; Yan X; Chen P; van der Flier LG; Nakatsukasa H; Neelapu SS; Chen W; Clevers H; Tian Q; Qi H; Wei L; Dong C
Nature; 2014 Mar; 507(7493):513-8. PubMed ID: 24463518
[TBL] [Abstract][Full Text] [Related]
20. Achaete-scute complex-like 2 regulated inflammatory mechanism through Toll-like receptor 4 activating in stomach adenocarcinoma.
Zheng E; Cai Z; Li W; Ni C; Fang Q
World J Surg Oncol; 2022 Aug; 20(1):266. PubMed ID: 36008864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
